Regenxbio (RGNX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RGNX Regenxbio

Watchlist

7.730
+0.500+6.92%

Close Dec 31 16:00 ET

7.620
-0.110-1.42%

Post 19:53 ET

382.98MMarket Cap-1.54P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Novartis Reports Positive Results for Intrathecal Zolgensma
Seeking AlphaDec 30, 2024 10:58 ET
PepGen Stock Craters 35% on FDA Clinical Hold
Seeking AlphaDec 16, 2024 09:56 ET
RBC Capital Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $35
Moomoo NewsDec 11, 2024 07:33 ET · Ratings
RBC Capital Sticks to Its Buy Rating for RegenXBio (RGNX)
TipRanksDec 11, 2024 06:39 ET · Ratings
Express News | Regenxbio Inc - to Offer and Sell Shares up to $150 Million
ReutersDec 9, 2024 16:48 ET
Express News | Regenxbio Inc - on Dec 9, Co Enters Sales Agreement With Leerink Partners
ReutersDec 9, 2024 16:48 ET

Comments

Stock_Drift

Oct 21, 2024 06:09

$Regenxbio (RGNX.US)$

Stock_Drift

Sep 23, 2024 15:16

$Regenxbio (RGNX.US)$

Bingrru

Aug 1, 2024 09:20

$Regenxbio (RGNX.US)$

Tao Lao Zoa

Mar 5, 2024 11:19

$Regenxbio (RGNX.US)$ SELL SELL SELL NOW EASY MONEY AND ENJOIN YOURS TAKE BREAK TOMORROW 💰💰💰😋😋😋🤩🤩🤩

Moomoo AI

Feb 17, 2024 07:06

Investors' pessimism about the company's revenue prospects may be causing the low P/S ratio. The company's forecast growth is lower than the wider industry, which could be contributing to the depressed P/S. It's hard to see the share price rising strongly in the near future given these circumstances.

There's No Escaping REGENXBIO Inc.'s (NASDAQ:RGNX) Muted Revenues Despite A 33% Share Price Rise

Heat List

Overall

No Data